Spots Global Cancer Trial Database for pancreatic cancer metastatic
Every month we try and update this database with for pancreatic cancer metastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety Study of Whole Body Hyperthermia for Advanced Cancer | NCT04467593 | Advanced Cancer Pancreatic Canc... | Whole body hype... Standard of Car... | 18 Years - 75 Years | ElmediX | |
| Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | NCT03504423 | Pancreatic Canc... | CPI 613, mFolfi... Folfirinox | 18 Years - 75 Years | Cornerstone Pharmaceuticals | |
| RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan | NCT06155136 | Pancreatic Canc... | 18 Years - | Servier | ||
| Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg | |
| Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer | NCT04799431 | Pancreatic Canc... Colorectal Canc... | Neoantigen Vacc... Retifanlimab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | NCT03504423 | Pancreatic Canc... | CPI 613, mFolfi... Folfirinox | 18 Years - 75 Years | Cornerstone Pharmaceuticals | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer | NCT04667403 | Adenocarcinoma Pancreatic Canc... Pain | Telemedicine | 18 Years - | Institut Cancerologie de l'Ouest | |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | NCT05642962 | Metastatic Panc... Metastatic Panc... Metastatic Panc... Metastatic Panc... Pancreatic Carc... Pancreatic Carc... Pancreatic Carc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... Pancreatic Canc... PDAC PDAC - Pancreat... | Pertzye | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg | |
| Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | NCT05047991 | Pancreatic Canc... Pancreatic Canc... | Irinotecan Lipo... Fluorouracil Leucovorin Oxaliplatin Nab paclitaxel Gemcitabine | 18 Years - 70 Years | CSPC Ouyi Pharmaceutical Co., Ltd. | |
| Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial | NCT04721301 | Colorectal Canc... Pancreatic Canc... | Nivolumab plus ... | 18 Years - | University Hospital Heidelberg | |
| A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | NCT04674956 | Pancreatic Canc... Pancreatic Canc... | Camrelizumab Paclitaxel(Albu... Placebo | 18 Years - | RenJi Hospital | |
| A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer | NCT06168812 | Pancreatic Canc... Pancreatic Carc... Pancreatic Duct... Pancreatic Canc... Metastatic Panc... Metastatic Panc... | Glipizide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy | NCT02959151 | Carcinoma, Hepa... Pancreatic Canc... Colorectal Canc... | CAR-T cell | 18 Years - 69 Years | Shanghai GeneChem Co., Ltd. | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | NCT01652976 | Pancreatic Canc... | Dasatinib mFOLFOX6 | 18 Years - | University of Florida | |
| RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan | NCT06155136 | Pancreatic Canc... | 18 Years - | Servier | ||
| INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer | NCT04116073 | Pancreatic Canc... Pancreatic Canc... | INCMGA00012 (PD... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer | NCT04667403 | Adenocarcinoma Pancreatic Canc... Pain | Telemedicine | 18 Years - | Institut Cancerologie de l'Ouest | |
| Safety Study of Whole Body Hyperthermia for Advanced Cancer | NCT04467593 | Advanced Cancer Pancreatic Canc... | Whole body hype... Standard of Car... | 18 Years - 75 Years | ElmediX | |
| Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | NCT05047991 | Pancreatic Canc... Pancreatic Canc... | Irinotecan Lipo... Fluorouracil Leucovorin Oxaliplatin Nab paclitaxel Gemcitabine | 18 Years - 70 Years | CSPC Ouyi Pharmaceutical Co., Ltd. | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute | |
| Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer | NCT06030622 | Pancreatic Canc... | Gemcitabine and... C3 (Metformin, ... | 18 Years - | State University of New York - Downstate Medical Center | |
| Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer | NCT05254171 | Pancreatic Canc... Pancreatic Duct... Pancreatic Canc... | SBP-101 Nab-paclitaxel Gemcitabine Placebo | 18 Years - | Panbela Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
